Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Keloids Clinical Trials
Keloids clinical trials are recruiting across 4 cities. Here are the cities with the most active studies:
About Keloids
Keloids are raised, overgrown scars that extend beyond the original wound boundaries, caused by excessive collagen production during wound healing. They can be painful, itchy, and cosmetically distressing. Treatment includes corticosteroid injections, silicone sheets, cryotherapy, and laser therapy.
Clinical trials are advancing new treatments for keloids. Currently, 4 studies are recruiting a combined 7,075 participants across the United States. Research is being conducted by 4 organizations including UConn Health, Icahn School of Medicine at Mount Sinai, Sonal Choudhary and 1 others.
2026 Keloids Research Landscape
As of July 2026, the keloids clinical trial landscape includes 4 actively recruiting studies across 4 cities in the United States. These studies are collectively seeking 7,075 participants, with an average enrollment target of 1,769 per study.
Research is being led by 4 different organizations, including UConn Health, Icahn School of Medicine at Mount Sinai, Sonal Choudhary, Montefiore Medical Center.
Geographically, keloids trials are most concentrated in Farmington, Connecticut (1 trial); New York, New York (1 trial); Pittsburgh, Pennsylvania (1 trial); The Bronx, New York (1 trial).
Featured Keloids Studies
Highlighted recruiting studies for keloids, selected by enrollment size and research scope.
Genetic Analysis of Keloids
Keloids have a strong genetic component. The goal of this study is to identify genes and regulatory elements on chromosomes that are the cause for keloids or contribute to keloid scarring.
Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy
Keloids are common, benign cutaneous overgrowths that manifest clinically as raised, hypertrophic, often hyperpigmented lesions which are formed in response to dermal injury or idiopathic stimuli. Although keloids are a common disease, it's exact incidence and prevalence is not known. Despite the debilitating nature of keloids, current treatment modalities are limited in efficacy; there is no univ...
Topical Cryotherapy and Keloid/Hypertrophic Scars
The goal of this clinical trial is to determine whether the application of brief topical cryotherapy immediately before intralesional corticosteroid injections can reduce pain and injection resistance during routine treatment of keloid and hypertrophic scars in adult patients. The main questions it aims to answer are: Does topical cryotherapy applied before intralesional triamcinolone injection ...
Frequently Asked Questions About Keloids Clinical Trials
Are there keloids clinical trials near me?
Yes, there are 4 keloids clinical trials currently recruiting across 4+ cities in the United States, including Farmington, Connecticut; New York, New York; Pittsburgh, Pennsylvania. Browse the studies above to find one at a location convenient for you.
How do I join a keloids clinical trial?
To join a keloids clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are keloids clinical trials free?
Yes, participation in keloids clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of keloids treatments are being studied?
Current keloids clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 4 research organizations.
Is it safe to participate in keloids clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 13, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 13, 2026 · Data from ClinicalTrials.gov